Description
HYNIC-PSMA is a ligand for molecular imaging of tumors. Hynic-psma consists of two components: HYNIC (6-hydrazinonicotinamide) and PSMA (Prostate-Specific Membrane Antigen). HYNIC is a compound used to attach radioactive isotopes to targeted molecules, such as 188Re-HYNIC-PSMA. PSMA is a membrane antigen that is specifically expressed on the surface of prostate cancer cells. HYNIC-PSMA can be used in prostate cancer research[1].—–C24H37N7O9—-[1]Hadisi M, et al. Preclinical evaluation of 188 Re-HYNIC-PSMA as a novel therapeutic agent[J]. Journal of Radioanalytical and Nuclear Chemistry, 2022, 331(2): 841-849. –2213408-17-2–567.59—-O=C([C@H](CCC(O)=O)NC(N[C@@H](CCCCNC(CCCCCNC(C1=CN=C(C=C1)NN)=O)=O)C(O)=O)=O)O–Cancer–10 mM in DMSO–PSMA—-Immunology/Inflammation–Peptides
Did you check our products for animal nutrition?